Compugen (CGEN) Enterprise Value (2009 - 2026)
Compugen's (CGEN) quarterly Enterprise Value came in at -$91.8 million in Q1 2026, down 29.13% year-on-year from -$129.5 million in Q1 2025, and up 32.71% quarter-over-quarter from -$136.4 million in Q4 2025.
Compugen (CGEN) Enterprise Value (2009 - 2026) Analysis & Trends
Compugen has disclosed Enterprise Value across 18 years of filings, most recently posting -$91.8 million for Q1 2026.
- Enterprise Value for Q1 2026 came in at -$91.8 million, down 29.13% year-over-year; the trailing twelve-month figure through Mar 2026 was -$91.8 million (down 29.13% YoY), and the FY2025 annual result was -$136.4 million, down 71.25% from the prior year.
- Enterprise Value came in at -$91.8 million for Q1 2026 at Compugen, up from -$136.4 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$11.1 million in Q4 2022 to a low of -$136.4 million in Q4 2025.
- The 5-year median for Enterprise Value is -$68.0 million (2025), against an average of -$70.9 million.
- Across the five-year window, Enterprise Value jumped 90.55% in 2022 and sank 252.14% in 2023, its largest moves.
- Compugen's Enterprise Value stood at -$11.1 million in 2022, then tumbled by 252.14% to -$38.9 million in 2023, then sank by 104.47% to -$79.6 million in 2024, then tumbled by 71.25% to -$136.4 million in 2025, then surged by 32.71% to -$91.8 million in 2026.
- The last three Enterprise Value figures came in at -$91.8 million (Q1 2026), -$136.4 million (Q4 2025), and -$59.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Compugen | 189.59 Mn | 97.83 Mn | 352,000.00 | -91.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -91.75 Mn |
| Dec 31, 2025 | -136.36 Mn |
| Sep 30, 2025 | -59.36 Mn |
| Jun 30, 2025 | -65.00 Mn |
| Mar 31, 2025 | -71.06 Mn |
| Dec 31, 2024 | -79.63 Mn |
| Sep 30, 2024 | -79.57 Mn |
| Jun 30, 2024 | -59.32 Mn |
| Dec 31, 2023 | -38.94 Mn |
| Jun 30, 2023 | -61.37 Mn |
| Dec 31, 2022 | -11.06 Mn |
| Jun 30, 2022 | -96.93 Mn |
| Dec 31, 2021 | -117.05 Mn |
| Jun 30, 2021 | -111.09 Mn |
| Dec 31, 2020 | -123.77 Mn |
| Jun 30, 2020 | -136.07 Mn |
| Dec 31, 2019 | -43.23 Mn |
| Jun 30, 2019 | -36.98 Mn |
| Dec 31, 2018 | -45.68 Mn |
| Jun 30, 2018 | -43.09 Mn |